Congestive Heart Failure & Angina

Welcome Nessage

Dear Esteemed Participants,

On behalf of the organizing committee, it is our great honor to welcome you to the 6^th World Congress on Congestive Heart Failure & Angina, scheduled for May 27–28, 2026, in Paris, France.

This year’s congress gathers leading cardiologists, researchers, clinicians, industry innovators, and healthcare professionals from across the globe to share knowledge, present the latest scientific advancements, and collaborate on strategies to transform the prevention, diagnosis, and management of heart failure and angina. With cardiovascular diseases continuing to be the leading cause of mortality worldwide, this congress serves as a vital platform to address emerging therapies, technological breakthroughs, and patient-centered care.

Whether you are joining as a speaker, presenter, or delegate, we encourage you to engage actively, exchange perspectives, and foster new collaborations. Together, let us advance the science and practice of cardiovascular medicine and shape a healthier future.

We look forward to welcoming you to Paris for an enriching and unforgettable experience of learning, networking, and innovation.

Warm regards,
Organizing Committee

About Conference

The 6^th World Congress on Congestive Heart Failure & Angina will be held on May 27–28, 2026, in Paris, France, bringing together global leaders, clinicians, scientists, researchers, and healthcare professionals to address the most pressing challenges in cardiovascular medicine. This premier event provides a dynamic forum for exchanging ideas, presenting cutting-edge research, and exploring the evolving landscape of cardiology.

The 2026 edition will spotlight a wide range of themes including pathophysiology of heart failure, advanced diagnostic tools, pharmacological and non-pharmacological therapies, interventional cardiology, regenerative medicine, and digital health innovations. With a comprehensive program of keynote lectures, symposia, oral and poster presentations, workshops, and panel discussions, the congress fosters collaboration between academia, industry, and clinical practice.

Whether you are a researcher driving new discoveries, a clinician enhancing patient outcomes, or an industry leader developing the next generation of cardiovascular solutions, this congress is your gateway to innovation and impact in the fight against heart failure and angina.

Conference Agenda

Registration & Kit Collection: Delegates will begin with registration, receiving ID badges, conference kits, and the full agenda. On-site staff will be available to assist with any queries. Early arrival is encouraged.

Inaugural Session & Opening Remarks: The congress opens with a welcome note from the organizing committee, followed by keynote addresses from distinguished cardiology experts. A group photograph will conclude the session.

Scientific Sessions & Presentations: Parallel tracks will cover specialized topics, from biomarkers and imaging in heart failure to surgical interventions and lifestyle medicine. Oral, poster, and e-poster presentations will provide opportunities for participants to showcase their work.

Networking Breaks & Poster Walks: Tea/coffee breaks and poster sessions will allow attendees to interact, share feedback, and connect with peers and exhibitors.

Conference Lunch & Awards Ceremony: Delegates will enjoy networking luncheons. On the final day, awards for best oral and poster presentations will be presented, along with certificates and closing remarks.

Optional Activities: Delegates may join guided city tours or special networking dinners to explore Paris and build professional relationships.

Why To Attend?

Because cardiovascular health is not just medicine—it’s life.

At the 6^th World Congress on Congestive Heart Failure & Angina, you’re not just attending another medical conference. You are joining a global effort to improve survival rates, enhance patient quality of life, and drive innovation in cardiovascular care.

This congress offers more than lectures—it’s a catalyst for action. Attendees will gain insights into cutting-edge therapies, groundbreaking clinical trials, and digital health solutions revolutionizing cardiology. Engage with global pioneers, explore new strategies, challenge existing paradigms, and build collaborations that transcend borders.

Participation / Presentation Options

We welcome participants in diverse formats designed to maximize engagement and learning opportunities:

• Oral Presentation (In-Person): Present your latest findings and receive live feedback from experts and peers.
• Poster Presentation (In-Person): Share your work visually and network during interactive poster sessions.
• E-Poster Presentation (Virtual): Present your research digitally for flexible access to online participants.
• Video Presentation (Virtual): Submit a pre-recorded talk featured in our digital gallery with global reach.
• Webinar Presentation (Live Virtual): Present live from your location to an international audience.
• Panelist Participation: Contribute to expert-led discussions on pressing issues in cardiovascular care.
• Workshop Facilitator: Lead hands-on workshops focusing on techniques, therapies, or technologies.
• Lightning Talk: Deliver a short, impactful presentation on emerging ideas or early-stage research.
• Listener / Attendee (In-Person or Virtual): Engage in sessions, networking, and discussions without presenting.
• Young Researcher Forum: A special platform for students and early-career professionals to share research and receive mentorship

Market Analysis

The global cardiovascular market continues to grow rapidly, driven by the rising prevalence of heart failure, aging populations, and innovations in treatment and diagnostics.

The global heart failure therapeutics market is projected to surpass USD 20 billion by 2030, fueled by advances in drug therapies and device technologies.

The cardiac devices market (including pacemakers, defibrillators, and ventricular assist devices) is expected to grow steadily at a CAGR of over 6% through 2030.

Digital health and remote monitoring in cardiology are expanding significantly, offering opportunities for tele-cardiology, AI-driven diagnostics, and wearable devices.

Regenerative medicine and gene therapy are emerging as promising frontiers for advanced heart failure treatment.

Global initiatives for preventive cardiology and lifestyle-based interventions are increasing, with a focus on reducing healthcare costs and improving patient outcomes.

The congress provides a unique opportunity for stakeholders to align with market trends, foster partnerships, and accelerate progress in the global fight against heart failure and angina.